Brief: Valbiotis SA Valbiotis Announces Approval To Launch Two Phase Ii/Iii Insight And Insight 2 Clinical Studies
Feb 17 (Reuters) - Valbiotis SA ALVAL.PA :
* VALBIOTIS ANNOUNCES APPROVAL TO LAUNCH TWO PHASE II/III
INSIGHT
AND INSIGHT 2 CLINICAL STUDIES
* THESE AUTHORIZATIONS ENABLE SIMULTANEOUS LAUNCH OF
RECRUITMENT
FOR THESE INTERNATIONAL STUDIES, WHICH SHOULD BE COMPLETED IN
FIRST HALF OF 2023
Source text for Eikon: ID:nBwDdZ5ya
Further company coverage: ALVAL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Valbiotis SA
See all newsBrief: Valbiotis Announces Creation By Chinese JV Of Subsidiary In Singapore
French and Benelux stocks-Factors to watch
Brief: Valbiotis FY Operating Profit Eur -9.5 Mln
Brief: Valbiotis Launches Capital Increase For Gross Amount Of Nearly EUR 6.9 Mln
Brief: Valbiotis Signs Strategic Agreements With Two Pharmaceutical Groups